Cytokinetics · 1 day ago
Intern – Biology Technologies
Cytokinetics is a specialty cardiovascular biopharmaceutical company focused on developing innovative medicines for cardiac muscle dysfunction. The Biology Technologies Intern will work on a summer project to develop and validate a phosphoproteomics workflow, collaborating with the Advanced Mass Spectrometry group to support drug discovery efforts.
BiopharmaBiotechnologyHealth Care
Responsibilities
Develop and document a reproducible phosphopeptide enrichment protocol for Biology Technologies
Optimize LC-MS acquisition parameters on the Bruker timsTOF flex for phosphoproteomics applications
Establish and validate a complete phosphoproteomics workflow from sample preparation through data analysis
Validate workflow performance using a defined biological perturbation to assess method robustness
Analyze and interpret phosphoproteomics datasets using Spectronaut
Apply the validated workflow to selected Biology Technologies targets
Maintain detailed experimental documentation and contribute to method standardization efforts
Provide regular project updates in group meetings and deliver a final presentation summarizing results and recommendations
Qualification
Required
Have completed at least two to four years at a US college or university at the time of the program with a focus in Biochemistry
Prior lab experience in biology or chemistry required with experience in biochemical assays preferred
Must be detail oriented and have a proactive attitude in support of research activities and running assays
Highly focused, organized and motivated team player with good time management skills
Excellent communication skills and the ability to troubleshoot problems with team members
Preferred
Pursuing a Graduate degree preferred
Prior experience in statistics/ data analysis is preferred
Experience with mammalian cell culture preferred
Company
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
H1B Sponsorship
Cytokinetics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (9)
2024 (9)
2023 (4)
2022 (6)
2021 (7)
2020 (4)
Funding
Current Stage
Public CompanyTotal Funding
$2.41BKey Investors
Royalty PharmaDeerfieldVulcan
2025-09-16Post Ipo Debt· $650M
2024-05-22Post Ipo Equity· $550M
2024-05-22Post Ipo Debt· $50M
Recent News
GlobeNewswire
2026-01-13
Company data provided by crunchbase